Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib

Published:2017-02 Issue:1 Volume:40 Page:47-52
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Cushen Samantha J.,Power Derek G.,Teo Min Y.,MacEneaney Peter,Maher Michael M.,McDermott Ray,O’Sullivan Kathleen,Ryan Aoife M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference36 articles.

1. Renal-cell carcinoma;Motzer;N Engl J Med,1996

2. Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology;Gore;Eur J Cancer,2012

3. Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis;Ibrahim;Int J Clin Oncol,2013

4. Targeted drugs for metastatic renal cell carcinoma;Motzer;Lancet,2007

5. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity;Prado;Clin Cancer Res,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body composition measures as a determinant of Alpelisib related toxicity;2024-01-17

2. Automatic deep learning method for third lumbar selection and body composition evaluation on CT scans of cancer patients;Frontiers in Nuclear Medicine;2024-01-10

3. A qualitative analysis of nutritional needs and dietary changes during cancer treatment in Ireland;Irish Journal of Medical Science (1971 -);2023-11-27

4. Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-09

5. Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma;Current Urology Reports;2023-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3